| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $11.58M | $35.38M | $29.39M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.18B | $689.52M | $498.76M | $293.66M | $217.40M |
| R&D | $987.33M | $592.23M | $423.14M | $253.07M | $186.95M |
| SG&A | $195.04M | $97.30M | $75.62M | $40.59M | $30.45M |
| Operating Income | -$1.18B | -$689.52M | -$487.19M | -$258.28M | -$188.01M |
| Interest Expense | – | – | – | $0.00 | $12.00K |
| Tax Expense | $0.00 | -$753.00K | -$3.52M | -$420.00K | $0.00 |
| Net Income | -$1.13B | -$600.09M | -$436.37M | -$248.71M | -$187.09M |
| EPS (basic) | -5.9500 | -3.5800 | -3.8600 | -3.0800 | -2.5700 |
| EPS (diluted) | -5.9500 | -3.5800 | -3.8600 | -3.0800 | -2.5700 |
| Shares (diluted) | $190.13M | $167.74M | $113.15M | $80.63M | $72.81M |